# 바이오스페이스 일일 뉴스 리포트 - 2025년 08월 19일


## 주요 헤드라인

1. **Leaked MAHA Strategy Emphasizes Vaccine Overhaul, Streamlined Access to Novel Therapies (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/leaked-maha-strategy-emphasizes-vaccine-overhaul-streamlined-access-to-novel-therapies>

2. **Leaked MAHA Strategy Emphasizes Vaccine Overhaul, Streamlined Access to Novel Therapies (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/leaked-maha-strategy-emphasizes-vaccine-overhaul-streamlined-access-to-novel-therapies>

3. **Merck KGaA Drops up to $2B in Skyhawk Collab for RNA-Targeting Tech (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/merck-kgaa-drops-up-to-2b-in-skyhawk-collab-for-rna-targeting-tech>

4. **Merck KGaA Drops up to $2B in Skyhawk Collab for RNA-Targeting Tech (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/merck-kgaa-drops-up-to-2b-in-skyhawk-collab-for-rna-targeting-tech>

5. **Novo Teams Up With GoodRx for Lower-Price GLP-1s, Giving DTC Another Shot (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-teams-up-with-goodrx-for-lower-price-glp-1s-giving-dtc-another-shot>

6. **Novo Teams Up With GoodRx for Lower-Price GLP-1s, Giving DTC Another Shot (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-teams-up-with-goodrx-for-lower-price-glp-1s-giving-dtc-another-shot>

7. **Pfizer’s $5.4B GBT Bet Disappoints Again as Sickle Cell Therapy Fails in Phase III (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/pfizers-5-4b-gbt-bet-disappoints-again-as-sickle-cell-therapy-fails-in-phase-iii>


---
*2025년 08월 19일 바이오스페이스 뉴스 피드에서 생성된 리포트*